|
2015
|
Invention
|
Conjugates for the administration of biologically active compounds.
The invention relates to a c... |
|
|
Invention
|
Agents and methods based on the use of the eda domain of fibronectin.
This invention relates to ... |
|
|
Invention
|
Compounds for use as antifibrinolytic agents. It relates to matrix metalloprotease (MMP) inhibito... |
|
|
Invention
|
New antifibrinolytic compounds. It relates to spirocyclic compounds of formula (I), or pharmaceut... |
|
2013
|
Invention
|
Immuno-stimulant combination for prophylaxis and treatment of hepatitis c.
The present invention... |
|
|
Invention
|
Antifibrinolytic compounds. 7 are as defined herein. It also relates to a process for their prepa... |
|
|
Invention
|
New antifibrinolytic compounds. It relates to spirocyclic compounds of formula (I),or pharmaceuti... |
|
|
Invention
|
Methods and reagents for the prognosis of cancer. The invention relates to a method for determini... |
|
|
Invention
|
Methods and compositions for the treatment of cirrhosis and liver fibrosis.
The invention provid... |
|
|
Invention
|
Lung cancer molecular markers. The invention provides a method of diagnosis and/or prognosis of l... |
|
|
Invention
|
New lung cancer molecular markers. The invention provides a method of diagnosis and/or prognosis ... |
|
2012
|
Invention
|
A non-human animal model of mucosa-associated lymphoid tissue (malt) lymphoma. The present invent... |
|
|
Invention
|
Tadalafil for the treatment of dementia. The present invention relates to tadalafil, pharmaceutic... |
|
|
Invention
|
Compostions designed for the inhibition and/or blocking of the epithelial/mesenchymal transition.... |
|
|
Invention
|
Peptides with the capacity to bind to interleukin-10 (il-10).
The invention relates to peptides ... |
|
|
Invention
|
Immunogenic compositions and methods for their use. The invention relates to immunogenic composit... |
|
2011
|
Invention
|
Propagative alphaviral expression vectors not forming functional nuclecapsids. The invention rela... |
|
|
Invention
|
New compositions and cell therapy methods for the treatment of cirrhosis. The present invention p... |
|
|
Invention
|
Cold organ preservation composition and method of use. The present invention relates to a cold or... |
|
|
Invention
|
Composition for the cold storage of organs. The invention relates to a composition for the cold s... |
|
|
Invention
|
Use of transforming growth factor - beta 1 (tgf-b1) inhibitor peptides for the treatment of corne... |
|
|
Invention
|
Use of transforming growth factor - beta 1 (tgf-β1) inhibitor peptides for the treatment of corne... |
|
|
Invention
|
Use of transforming growth factor - beta 1 (tgf-.beta.1) inhibitor peptides for the treatment of ... |
|
|
Invention
|
Compositions based on the fibronectin extracellular domain a for the treatment of melanoma. The i... |
|
|
Invention
|
Compositions for the treatment of infectious and tumoural diseases.
The present invention relate... |
|
|
Invention
|
Compositions for the treatment of infectious and tumoural diseases comprising an osmr agonist and... |
|
2010
|
Invention
|
New conjugates and compositions for immunotherapy and antitumoral treatment. The present inventio... |
|
|
Invention
|
Conjugates and compositions for immunotherapy and anti-tumor treatment. The present invention rel... |
|
|
Invention
|
Viral vectors and methods used in the preparation of gdnf. The invention relates to a method for ... |
|
|
Invention
|
Regulated expression system. The application relates to gene constructs for inducible hepato- spe... |
|
|
Invention
|
Regulated expression systems. The application relates to gene constructs for inducible hepato- sp... |
|
|
Invention
|
Use of 5' -methylthioadenosine for the inhibition of the epithelial-mesenchymal transition. A des... |
|
|
Invention
|
Compounds and compositions for the treatment of illnesses caused by the hepatitis b virus. The in... |
|
|
Invention
|
Therapeutic compositions for the treatment of hpv-induced diseases.
The invention relates to imm... |
|
|
Invention
|
Therapeutic compositions for the treatment of hpv-induced diseases. The invention relates to immu... |
|
|
Invention
|
Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments. The present invention re... |
|
|
Invention
|
Neuroprotective properties of 5'-methylthioadenosine.
The present invention relates to the use o... |
|
|
Invention
|
Neuroprotective properties of 5'-methylthioadenosine. The present invention relates to the use of... |
|
|
Invention
|
5'-methylthioadenosine neuroprotective properties. The present invention relates to the use of MT... |
|
2009
|
Invention
|
Oncostatin m as promoter of immunostimulatory activity of human epithelial cells.
The invention ... |
|
|
Invention
|
Porphobilinogen deaminase gene therapy. The present invention relates to nucleotide sequences cod... |
|
|
Invention
|
System for packaging high-capacity adenoviruses.
The invention relates to a nuew system for prod... |
|
|
Invention
|
Adapter molecule for the delivery of adenovirus vectors.
The invention relates to an adapter pro... |
|
|
Invention
|
Self-inactivating helper adenoviruses for the production of high-capactiy recombinant adenoviruse... |
|
|
Invention
|
Synergistic 5′-methylthioadenosine combinations. The present invention relates to combinations of... |
|
|
Invention
|
Methods and compositions capable of causing post-transcriptional silencing of gene expression in ... |
